Close

Search

Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Eikon Therapeutics Closes $148M Financing Round, Names CEO

Facebook Twitter LinkedIn Email
Drug discovery and development company Eikon Therapeutics closed $148 million in Series A financing and appointed Roger Perlmutter CEO. Eikon’s drug discovery platform uses superresolution microscopy, an approach that elucidates the behavior of proteins in live cells. Superresolution microscopy was developed by Eric Betzig and collaborators, who received the Nobel Prize in chemistry in 2014. The company’s Scientific Advisory Board (SAB) includes Betzig, who is a co-founder of Eikon Therapeutics. Perlmutter was previously an executive vice president at Merck and president of...Read full article

Related content from Photonics Media



    ARTICLES


    PRODUCTS


    PHOTONICS HANDBOOK ARTICLES


    WHITEPAPERS


    WEBINARS


    PHOTONICS DICTIONARY TERMS


    MEDIA


    PHOTONICS BUYERS' GUIDE CATEGORIES


    COMPANIES

    LATEST HEADLINES
    view all
    PHOTONICS MARKETPLACE
    Search more than 4000 manufacturers and suppliers of photonics products and services worldwide:

    back to top
    Facebook Twitter Instagram LinkedIn YouTube RSS
    ©2022 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

    Photonics Media, Laurin Publishing
    x Subscribe to BioPhotonics magazine - FREE!
    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.